Brief: Aequus provides corporate update on commercial and development programs
Aug 30 (Reuters) - Aequus Pharmaceuticals Inc AQS.V
* Aequus provides corporate update on commercial and
development programs
* Net loss for quarter of $1.39 million compared to $1.14
million in 2015
Source text for Eikon: ID:nCCN87yS06
Further company coverage: AQS.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange